Recent studies have identified the transcription factor Pax5 as a critical determinant of commitment to the B-lymphocyte pathway. Surprisingly, Pax5 appears to achieve this primarily through suppressing alternative haematopoietic lineage fates.
Selecting a cell lineage from two or more possibilities represents a fundamental, and unavoidable, developmental decision associated with the multicellular state of the metazoa. The vertebrate haematopoietic system has provided a key model system in which to examine the mechanisms underlying such lineage commitment decisions. Many candidate molecular players in the haematopoietic lineage game have been identified but, when tested using gene knockout approaches in mice, have apparently failed to alter commitment decisions [1] . That was at least until now. B cells lacking the transcription factor Pax5 cannot complete all the stages of Bcell differentiation. Nevertheless they appear, to all intents and purposes, to represent authentic immature B lymphocytes, termed pro-B cells, that are stalled at a very early stage of development. Busslinger and colleagues [2, 3] now show that these ostensibly committed cells are nothing of the sort. Though superficially masquerading as B lymphocytes, these Pax5-deficient cells exhibit many of the molecular and functional characteristics of uncommitted multipotential stem cells and, in fact, can differentiate down a number of other haematopoietic lineages. So Pax5 apparently commits cells to a B-cell fate by closing the door on other potential cell fates. It would seem that in the age-old dilemma of to B or not to B, Pax5 is the deciding factor.
There are two major lineage commitment issues that surround the blood system ( Figure 1 ). The first concerns how haematopoietic stem cells themselves are generated from embryonic mesoderm during ontogeny. The second relates to how the resulting pluripotent haematopoietic stem cells undergo the commitment processes that give rise to the multiple cell lineages that constitute the blood. It is superficially tempting to consider that these processes occur by similar mechanisms. The biological imperatives of these two commitment processes are quite different, however, and thus may place quite distinct constraints on the underlying molecular machinery. Ontogeny is in some senses a 'one-off' event, and there is no reason to think that the formation of blood tissues during embryogenesis is in principle controlled substantially differently from that of any other tissue type. Indeed, from what we know so far, it would seem that the specification of blood from mesoderm is regulated by many of the same positional cues that dorso-ventrally pattern the mesoderm and generate other mesodermal derivatives, such as muscle and vascular endothelium [1] .
Once formed during ontogeny, these haematopoietic stem cells must service a lifetime's supply of blood. When we consider that the turnover of cells in the adult human blood system is in the order of one trillion cells per day, it is easy to see that the scale of the problem is formidable. And it is made no less daunting by the fact that stem cell numbers are themselves very small, and only a handful of stem cells are thought to contribute to haematopoiesis at any given moment. A critical feature of haematopoietic stem cells, therefore, is their ability to sustain their numbers -a process termed self-renewal -while still servicing the requirement for differentiated cells [4] . Striking a balance between self-renewal and differentiation, as well as between the alternative stem cell options of dormancy and apoptosis, is quite a tall order. So how is it achieved?
Since lineage restriction presumably entails the formation of stable transcription complexes that elaborate lineage-specific programmes of gene expression, we can be reasonably confident that transcription factors have something to do with the whole process. Many candidate transcription factors have been identified by either their expression profiles, their ability to bind to key cis-acting regulatory elements of lineage-affiliated genes or their association with leukaemia. The roles of many of these factors in haematopoiesis have been illuminated by knockout experiments in mice [1] . These experiments have primarily identified the particular developmental level or cellular stage at which the activity of a given transcription factor first becomes critical. In some instances, there have been striking effects on given lineages with marked changes in the quantity or functional capacity of mature effector cells. Although such perturbations often carry lethal consequences for the mice, the defects in the development of these particular blood lineages appear, for the most part, to occur downstream of a lineage-commitment checkpoint. For example, in the absence of the erythroid-affiliated transcription factor GATA-1, mice die of anaemia because mature oxygen-carrying red blood cells do not form. Although erythroid commitment is intact in these mice, erythroid lineage progression stalls at the pro-erythroblast stage. From this kind of experiment, GATA-1 would appear not to be required for commitment to the erythroid lineage.
Forced or ectopic expression experiments provide a quite different view from the knockout studies [5] . For example, enforced expression of GATA-1 in a variety of different non-committed haematopoietic cell lines has been shown to result in apparent unilineage commitment and differentiation. In the most striking of cases, the levels of GATA-1 overexpression actually determine the particular lineage produced. So knockout and misexpression experiments seem to lead to quite different conclusions with regard to GATA-1 and commitment -is this a potential paradox? Maybe not, but hold that thought: the recent example of Pax5 may provide a plausible solution to this particular conundrum.
Pax5 is a paired-domain transcription factor which, within the haematopoietic system, is expressed exclusively in the B-lymphocyte lineage. In the absence of Pax5, B-lymphocyte lineage progression stalls at the pro-B cell stage in vivo. Although Pax5-deficient pro-B cells can be propagated in vitro under appropriate culture conditions, that is, in the presence of interleukin-7 (IL-7) and stromal cells, further progression down the B-lymphocyte lineage is prevented unless Pax5 is reintroduced into the cells. On the face of it, this seems all too familiar, just another lineage-affiliated transcription factor that is important for completing the differentiation or maturation programme, but not essential for commitment to the lineage per se.
And that's where it may all have ended if the Pax5-deficient pro-B cell cultures, when left to their own devices, had not eventually exhausted their supply of IL-7 [2] . While control B-lymphocyte cultures matured and died, their Pax5-deficient counterparts survived, albeit in an apparently transmuted form looking rather more like myeloid than lymphoid cells. This was the proverbial crack through which Busslinger and colleagues [2] drove the wedge. By culturing Pax5-deficient pro-B cells under appropriate conditions in the presence of cytokines that drive the development of various different haematopoietic lineages, a previously unimagined repertoire of haematopoietic lineage potentials was revealed ( Figure 2 ). These pro-B cells could be entrained into macrophage, dendritic cell, osteoclast, granulocyte and natural killer cell fates in vitro. Most striking of all, when introduced into T-cell deficient mice, Pax5-deficient pro-B cells could reconstitute T-cell development in vivo [3] . The apparent multipotentiality of Pax5-deficient pro-B cells was confirmed by cell-cloning experiments to be a property of individual cells.
Some aspects of the plasticity of differentiation exhibited by these Pax5-deficient pro-B cells have been previously hinted at in a variety of other studies of the early B-lymphocyte compartment (see [6] and references therein). Studies of normal and experimentally induced leukaemias point to a close developmental connection between B-lymphocyte and macrophage lineages, which has been further supported by the identification of a common B-lymphocyte-macrophage progenitor. Functional experiments have further shown that certain immortalised pre-B cell lines can be induced to transdifferentiate into macrophages. Clearly the range of differentiation potentials shown by these Pax5-deficientbut otherwise normal -pro-B cells considerably ups the ante and begs their comparison with bona fide haematopoietic stem cells. But Pax5-deficient pro-B cells have so far failed the most stringent of stem cell tests -the ability to rescue the haematopoietic systems of lethally irradiated mice. It would appear, therefore, that these cells cannot differentiate down all the haematopoietic lineage pathways in vivo, and so far have also not been able to produce erythroid or megakaryocytic cells in vitro. Analysis of the molecular features of these cells, however, reveals some striking similarities with the stem/multipotential cell compartment [2] .
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Figure 1
The lineage relationships of blood. Multiple blood lineages are specified from a pool of self-renewing multipotential stem cells that originally form from the embryonic mesoderm. Colours are used to illustrate the idea that certain 'components' of all the different possible downstream fates are simultaneously available at subcritical levels in multipotent stem cells. It has been proposed that, under conditions of selfrenewal, multipotential haematopoietic progenitor cells simultaneously prime several different lineage-affiliated programs of gene activity [7] . This is apparent from the level of chromatin accessibility of certain cis-regulatory elements of lineage-affiliated loci and the low-level transcription of candidate lineage regulators. One interpretation of these data is that multilineage priming provides a ground-state level of multilineage 'noise', which in turn provides multiple starting points for lineage-affiliated circuits or 'loops' of gene activity that could have both interactive and competitive properties [8] . This provides a framework in which lineage specification could arise as a simple threshold event that is probabilistic or stochastic in nature. In such a scheme, unilineage commitment and differentiation not only involves the consolidation of appropriate programs of gene activity, but also requires the repression of primed programs that are no longer appropriate for differentiation down the lineage selected.
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Molecular analysis of Pax5-deficient pro-B cells reveals something of a reversion to this putatively 'promiscuous' molecular ground state of multipotential stem cells. Thus in addition to B-cell-associated genes, Pax5-deficient cells also express, to varying levels, genes characteristic of other haematopoietic lineages. These include myeloperoxidase and the macrophage colony-stimulating factor (M-CSF) receptor (myeloid-specific), the pre-T-cell receptor α chain (T-cell-specific), perforin (natural killer cell specific) and GATA-1. The low-level activation of lineage-promiscuous expression presumably provides the molecular framework from which lineage fates can be extricated from the Pax5-deficient pro-B cells. For example, the ability of these cells to develop into monocytes in response to M-CSF is presumably due to their expression of M-CSF-receptor. This promiscuity in gene expression is not observed in wild-type pro-B cells and, importantly, is abolished in Pax5-deficient cells when Pax5 expression is restored by retroviral transduction.
These data also argue that the primary role of Pax5 in commitment to the B-lymphocyte lineage lies in its ability to repress other lineage options and perhaps provide a potential solution to the GATA-1 conundrum raised earlier: if the primary role for a transcription factor in commitment is to close the door on other options, it would most easily be scored functionally by misexpression. These new data also suggest that a re-investigation of previously generated knockout mice for as yet untested lineage potentials might be fruitful. Finally, it is interesting to note that Pax5 is mono-allelically expressed in early haematopoietic progenitors [9] . Mathematical modelling of haplo-insufficiency syndromes has shown that expression of mono-allelically expressed genes can readily result in large 'spikes' of protein product levels [10] . Such a mechanism might underlie the apparently stochastic nature of lineage specification in haematopoiesis. 
